US Broker Ratings

Solventum Corporation (SOLV)

❌ Error generating article: Client error: `POST https://api.openai.com/v1/chat/completions` resulted in a `400 Bad Request` response: { “error”: { “message”: “We could not parse the JSON body of your request. (HINT:..

Haleon plc (HLN) Stock Report: Exploring a 23.39% Potential Upside in the Healthcare Giant

Haleon plc (HLN), the British healthcare behemoth, commands a significant presence in the drug manufacturing sector, specializing in both specialty and generic products. With a robust market capitalization of $43.75..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 28% Upside Potential Lures Investors

For investors with a keen eye on the healthcare sector, Koninklijke Philips N.V. (PHG) represents a notable opportunity, particularly given its potential upside of 28.27%. As a prominent player in..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking the 75.67% Potential Upside for Investors

Summit Therapeutics Inc. (NASDAQ: SMMT), a key player in the biotechnology sector, has been turning heads with its remarkable market cap of $12.86 billion. The company, headquartered in Miami, Florida,..

Natera, Inc. (NTRA) Stock Analysis: A Promising 41.86% Upside Potential in the Healthcare Diagnostics Sector

In the competitive landscape of the healthcare diagnostics sector, Natera, Inc. (NASDAQ: NTRA) stands out with its innovative molecular testing services and a robust growth trajectory. With a market capitalization..

United Therapeutics Corporation (UTHR)

⚠️ No article content returned.

..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 46% Potential Upside

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector specializing in medical care facilities, offers a compelling proposition for investors. Based in Birmingham, Alabama, the company has..

Bio-Rad Laboratories, Inc. (BIO) Stock Report: Exploring a 21% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a venerable name in the healthcare sector, has piqued the interest of investors with its robust potential upside. With a market capitalization of $7.17 billion,..

Novo Nordisk A/S (NVO) Stock Analysis: Exploring the 29.88% Potential Upside and Robust Dividend Yield

Novo Nordisk A/S (NVO), a titan in the healthcare sector, is making waves in the drug manufacturing industry as it continues to innovate in the fields of diabetes and obesity..

Elanco Animal Health (ELAN) Stock Analysis: Impressive Revenue Growth Amidst Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) has captured the attention of investors with its dynamic position in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a Promising 79% Upside Potential

Investors eyeing opportunities in the biotechnology sector may want to consider Corcept Therapeutics Incorporated (NASDAQ: CORT), a company that stands out with its innovative approach to treating severe endocrinologic, oncologic,..

BioNTech SE (BNTX) Investor Outlook: Exploring a 53% Potential Upside Amidst Market Challenges

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured investor attention with its significant footprint in the healthcare industry. Headquartered in Mainz, Germany, this company has..

Option Care Health, Inc. (OPCH) Stock Analysis: Unpacking a 47% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) is a compelling player in the healthcare sector, catering specifically to the medical care facilities industry. This Illinois-based company leads the charge in providing..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings and a 27.55% Potential Upside

Abbott Laboratories (NYSE: ABT), a cornerstone in the healthcare sector, continues to be a compelling option for investors seeking exposure to the medical devices industry. With a robust market capitalization..

Alkermes plc (ALKS) Stock Analysis: Unlocking a Potential 48% Upside Amidst Healthcare Innovation

For investors seeking opportunities in the healthcare sector, Alkermes plc (NASDAQ: ALKS) presents an intriguing prospect. This Ireland-based biopharmaceutical company, with a market cap of $4.9 billion, is making waves..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare with a 12% Upside Potential

Teleflex Incorporated (NYSE: TFX), a noteworthy player in the healthcare sector, is garnering attention from investors with its promising potential upside of 12.05%. As a key provider in the medical..

Agilent Technologies, Inc. (A) Stock Analysis: Strong Analyst Buy Ratings Signal 48% Potential Upside

Investors eyeing Agilent Technologies, Inc. (NYSE: A) might find the current market dynamics quite compelling. With a market capitalization of $31.18 billion, Agilent operates within the Healthcare sector, specifically in..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Investors Eye a 25% Upside Potential in Biotech Innovator

Roivant Sciences Ltd. (NASDAQ: ROIV) has been catching the attention of investors with its ambitious pipeline in the biotechnology sector. Based in the United Kingdom, this clinical-stage biopharmaceutical company is..

Stevanato Group S.p.A. (STVN): Consensus Points to 87% Upside Potential for This Healthcare Innovator

Stevanato Group S.p.A. (NYSE: STVN), a leader in the healthcare sector specializing in medical instruments and supplies, is drawing attention from investors with its significant upside potential. With an average..

Axsome Therapeutics (AXSM) Stock Analysis: Exploring 43% Upside Potential Amid Robust CNS Pipeline

Investors with a keen interest in the biotech sector may want to keep a close eye on Axsome Therapeutics, Inc. (NASDAQ: AXSM), a company that has carved out a niche..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds